期刊文献+

GnRHⅡ蛋白在子宫内膜异位症患者中的表达及意义 被引量:2

Expression of GnRHⅡ protein in patients with endometriosis and its significance
下载PDF
导出
摘要 目的:检测GnRHⅡ蛋白在子宫内膜异位症患者异位子宫内膜、在位子宫内膜和正常子宫内膜中的表达情况,同时分析其表达是否与子宫内膜月经周期有关。方法:采用免疫组织化学SP法检测GnRHⅡ蛋白在异位内膜、在位内膜及正常子宫内膜组织中的表达情况,并分析和比较其表达是否有差异。结果:GnRHⅡ蛋白在子宫内膜异位症患者异位、在位子宫内膜及正常子宫内膜中均有表达,阳性表达定位于子宫内膜腺体及间质细胞的细胞质;GnRHⅡ蛋白在异位内膜、在位内膜及对照组正常内膜的表达依次增强,两两比较差异有统计学意义(P<0.05);GnRHⅡ蛋白在正常子宫内膜分泌期表达强于增生期(P<0.05),且以分泌早中期最强,显著强于增生期和分泌晚期(P<0.01),而异位组或在位组的分泌期与增生期比较,差异无统计学意义(P>0.05)。结论:GnRHⅡ蛋白在子宫内膜异位症的发病中以及在人类月经生理方面可能起重要作用。 Objective To examine expression of GnRHⅡ protein in patients with-and without-endometriosis and to determine its relation to the menstrual cycle.Methods The expression of GnRHⅡ protein was detected in the normal,ectopic,eutopic endometrial tissues in women with-and without-endometriosis via immunohistochemistry SP method.Results GnRHⅡ was located in the cytoplasm of endometrial stromal cells and gland cells in all specimens.The expression of GnRHⅡ was lower in the ectopic endometrium than that in eutopic endometrium of patients with endometriosis(P〈0.05),and it was lower in the eutopic and ectopic endometrium of patients with endometriosis than that in the endometrium of women without endometriosis(P〈0.05).The expression of GnRHⅡ was obviously higher in the early and middle secretory phase than that in the hyperplasia phase in normal endometrium(P〈0.05).However,there was no significant difference between the eutopic and ectopic endometrium in patients with endometriosis in the menstrual cycle(P〉0.05).Conclusion The expression of GnRHⅡ in the ectopic and eutopic endometrium may play a crucial role in the pathogenesis of endometriosis and human menstrual physiology.
作者 邹颖 黄凤英
出处 《国际病理科学与临床杂志》 CAS 2010年第1期27-32,共6页 Journal of International Pathology and Clinical Medicine
关键词 子宫内膜异位症 GnRHⅡ蛋白 子宫内膜 免疫组织化学 endometriosis GnRHⅡ endometrium immuneohistochemistry
  • 相关文献

参考文献14

  • 1Millar RP.GnRHⅡ and type Ⅱ GnRH receptors[J].Trends Endocrinol Metab,2003,14(1):35-43.
  • 2丰有吉,沈铿.妇产科学[M].北京:人民卫生出版社,2008.272-275.
  • 3Olive DL.Gonadotropin-releasing hormone agonists for endometriosis[J].N Engl J Med,2008,359(11):1136-1142.
  • 4邓姗,郎景和,冷金花,刘珠凤,孙大为,朱兰,谭先杰.药物治疗对子宫内膜异位症患者在位内膜凋亡的影响[J].中国医学科学院学报,2007,29(2):252-256. 被引量:14
  • 5Enomoto M,Endo D,Kawashima S,et al.Human Type Ⅱ GnRH receptor mediates effects of GnRH on cell proliferation[J].Zool Sci,2004,21(7):763-770.
  • 6Grundker C,Gunthert AR,Millar RP,et al.Expression of gonadotropin-releasing hormone II (GnRH-Ⅱ) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation[J].J Clin Endocrinol Metab,2002,87(3):1427-1430.
  • 7Noyes RW,Hertig AT,Rock J.Dating the endometrial biopsy[J].Fertil Steril,1950,1(1):3-25.
  • 8Ozkara SK,Corakci A.Significantly decreased P27 expression in endometrial carcinoma compared to complex hyperplasia with atypia(correlation with p53 expression)[J].Pathol Oncol Res,2004,10(2):89-97.
  • 9Morimoto C,Osuga Y,Yano T,et al.GnRH II as a possible cytostatic regulator in the development of endometriosis[J].Hum Reprod,2005,20(11):3212-3218.
  • 10韩利伟,姜卫国.GnRHa对子宫内膜异位症内膜间质细胞生长增殖及血管形成的影响[J].现代妇产科进展,2008,17(10):737-740. 被引量:10

二级参考文献29

共引文献438

同被引文献26

  • 1陈建林,林秋华,方小玲,陶光实,黄凤英.孕酮对异位子宫内膜间质细胞MMP-2和MMP-9表达的影响[J].中南大学学报(医学版),2005,30(3):307-311. 被引量:5
  • 2迟晓丽,周文霞,张永祥,程军平.Ⅱ型GnRH及其受体系统研究进展[J].军事医学科学院院刊,2006,30(2):169-173. 被引量:4
  • 3秦莉花,秦明春,李晟,王若光,刘小丽,李春梅,吴长虹.人子宫内膜细胞原代体外培养方法[J].湖南中医药大学学报,2007,27(3):8-10. 被引量:13
  • 4郭瑞霞,魏丽惠.子宫肌瘤的药物治疗现状[J].中国妇产科临床杂志,2007,8(4):305-307. 被引量:6
  • 5丰有吉,沈铿.妇产科学[M].北京:人民卫生出版社,2010,7(2):60.
  • 6Millar R P. GnRH Ⅱ and type Ⅱ GnRH receptors [ J ]. Trends Endocrinol Metab,2003, 14( 1 ) :35-43.
  • 7Enomoto M, Endo D, Kawashima S,et al. Human type Ⅱ GnRH receptor mediates effects of GnRH on cell proliferation[ J]. Zool Sci,2004,21 ( 7 ) : 763 -770.
  • 8Grundker C, Gunthert A R, Millar R P, et al. Expression of gonadotropin-releasing hormone Ⅱ (GnRH-Ⅱ) receptor in hu- man endometrial and ovarian cancer cells and effects of GnRH- Ⅱ on tumor cell proliferation [ J ]. J Clin Endocrinol Metab, 2002,87 (3) : 1427-1430.
  • 9Meldrum D R, Chang R J, Lu J, et al. "Medical oophorecto- my" using a long-acting GNRH agonist--A possible new ap- proach to the treatment of endometriosis [ J ]. J Clin Endocrinol Metab, 1982,54(5) :1081-1083.
  • 10Klemmt P A, Carver J G, Kennedy S H, et al. Stromal cells from endometriotic lesions and endometrium from women with endometriosis have reduced decidualization capacity[ J]. Fertil Steri1,2006,85 (3) :564-572.

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部